1 results match your criteria: "37256Shamir (Assaf Harofeh) Medical Center[Affiliation]"
The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.
Sci Prog
June 2022
The Gonczarowski Family Institute of Gastroenterology and Liver Disease, 37256Shamir (Assaf Harofeh) Medical Center, Zerifin, 70300, Israel.
Background: Direct-acting antiviral (DAA) regimens and telemedicine services are both options for treating hepatitis C virus (HCV) within the prison setting. We aimed to compare factors associated with HCV treatment success over the past decade in Israeli prisons, specifically the influence of DAAs and telemedicine.
Methods: We retrospectively reviewed the medical records of inmates with HCV infection in Israeli prisons from 2010 through 2020.